Cholera Vaccines Oral Live Market – 2019-2025
Market Overview
The growth of the global cholera vaccines market can be attributed to multiple factors, such as the increasing incidences of cholera, rising initiatives by public and private entities, and growing awareness regarding cholera across the world. In 2017, 10 million doses of oral cholera vaccines were funded in affected countries via stockpile. This stockpile has been accessed 52 times since the funding, by 18 countries across the world, including Sierra Leone and Haiti. However, a lack of access to adequate care for cholera, coupled with a large number of unreported cases, are expected to pull back the growth of the market.
Get Sample Report PDF >>
The following manufacturers are covered:
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia
Scope of the Report
Cholera is caused by Vibrio cholerae via the consumption of contaminated food or water. The infected individuals suffer from severe watery diarrhea, eventually leading to dehydration, which if unattended, may lead to death, owing to access water loss. Oral vaccination has been observed to be the best preventive treatment for cholera and has proved to be very useful to prevent huge outbreaks. There are two basic types of vaccines given for cholera: whole-cell V. cholerae O1, in combination with a recombinant B-subunit of cholera toxin (WC/rBS), and killed oral O1 and O139.
Segment by Type
Dukoral
Shanchol
Vaxchora
Others
Segment by Application
Hospital
Scientific Research
Others
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
Browse Report »
Key Market Trends
Whole-cell V. cholerae O1 with a Recombinant B-subunit Segment Captures the Largest Market Share
This oral cholera vaccine containing a combination of recombinant B-subunit and killed whole cell V. cholerae O1 has been marketed since early 1990. This vaccine is observed to provide 80-90% protection for six months, post immunization, and in all the cases of immunization of vaccines aged more than 2 years. In addition to this, this vaccines shows around 50% of protection even after three years of immunization. Hence, the efficacy and long-lasting post immunization protections of the vaccine are expected to propel the segment’s growth over the forecast period.
North America is Expected to Grow at a High Rate over the Forecast Period
Asia-Pacific captures the largest market share in the global cholera vaccines market, followed by Europe. This can be attributed to the high incidence rate, growing awareness, and availability of efficient preventive solutions. The APAC market experienced exceptional growth since the launch of the oral cholera vaccine, Shanchol, in 2009. According to the statistics of WHO, 42 countries reported 172,454 cases of cholera in 2015, with 1,304 deaths. This statistics showed an overall decrease of 9% from the previous year, owing to growing immunization in the region. On the other hand, North America is expected to exhibit the fastest growth rate over the forecast period, owing to the launch of the first ever oral cholera vaccine, Vaxchora, in 2016, and the rise in the number of immigrants.
Competitive Landscape
Some of the significant companies in the market are AstraZeneca, Shantha Biotechnics Private Limited, Valneva SE, Merck & Co. Inc., and PaxVax Inc. The major market players, in order to retain a strong market position, focus on mergers, acquisitions, and product innovation. Also, licensing rights on the vaccines of some major companies give them the leverage of a strong market foothold. For instance, the licensing rights of Dukoral were conferred to Valneva SE, post-acquisition of Crucell Sweden AB, in turn, strengthening the company’s cholera vaccine portfolio and overall market position.
Customization of the Report
- Value chain analysis
- Consumer behavior analysis at country level
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Cholera Vaccines Oral Live Speaker Market;
3.) the North American Cholera Vaccines Oral Live Speaker Market;
4.) the European Cholera Vaccines Oral Live Speaker Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
Table of Content:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
…
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
16 Appendix
The key insights of The report Research:
1.The report Research provides key statistics on the market status of the Cholera Vaccines Oral Live manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report Research provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report Research presents the company profile, product specifications, capacity, production value, and 2019-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report Research estimates 2019-2025 market development trends of Cholera Vaccines Oral Live industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report Research makes some important proposals for a new project of Cholera Vaccines Oral Live Industry before evaluating its feasibility.
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Continued …
About Us:
“Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories”.
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Sales@Wiseguyreports.Com
Http://Www.Wiseguyreports.Com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
